Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott T Miller

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
American Journal of Hematology|September 29, 2011
Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodesCarlton D Dampier, Wally R Smith, Hae-Young Kim, et al.
British Journal of Haematology|April 3, 2012
Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)Lori Styles, Carrie G Wager, Richard J Labotka, et al.
Pediatric Blood & Cancer|September 5, 2009
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study designBruce W Thompson, Scott T Miller, Zora R Rogers, et al.
Clinical Trials (London, England)|March 30, 2013
IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studiesCarlton D Dampier, Wally R Smith, Carrie G Wager, et al.
The Journal of Pediatrics|October 23, 2003
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccinationThomas V Adamkiewicz, Sharada Sarnaik, George R Buchanan, et al.
The New England Journal of Medicine|July 19, 2018
A Phase 3 Trial of l-Glutamine in Sickle Cell DiseaseYutaka Niihara, Scott T Miller, Julie Kanter, et al.
Lancet (London, England)|May 17, 2011
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)Winfred C Wang, Russell E Ware, Scott T Miller, et al.
Lancet (London, England)|December 17, 2015
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E Ware, Barry R Davis, William H Schultz, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
American Journal of Hematology|September 29, 2011
Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodesCarlton D Dampier, Wally R Smith, Hae-Young Kim, et al.
British Journal of Haematology|April 3, 2012
Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)Lori Styles, Carrie G Wager, Richard J Labotka, et al.
Pediatric Blood & Cancer|September 5, 2009
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study designBruce W Thompson, Scott T Miller, Zora R Rogers, et al.
Clinical Trials (London, England)|March 30, 2013
IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studiesCarlton D Dampier, Wally R Smith, Carrie G Wager, et al.
The Journal of Pediatrics|October 23, 2003
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccinationThomas V Adamkiewicz, Sharada Sarnaik, George R Buchanan, et al.
The New England Journal of Medicine|July 19, 2018
A Phase 3 Trial of l-Glutamine in Sickle Cell DiseaseYutaka Niihara, Scott T Miller, Julie Kanter, et al.
Lancet (London, England)|May 17, 2011
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)Winfred C Wang, Russell E Ware, Scott T Miller, et al.
Lancet (London, England)|December 17, 2015
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E Ware, Barry R Davis, William H Schultz, et al.
Pageof 5